CLBT
Cellebrite DI
11.10$
-1.1%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | +30.0% | -6.8% | +18.7% | +32.1% | +29.6% | +36.0% | |
| – | +23.8% | -15.7% | +8.3% | +42.6% | +34.5% | +1.5% | |
| – | +68.1% | +13.4% | -40.0% | +116.2% | +1.1% | -35.1% | |
| – | +18.7% | -23.6% | +1.1% | +65.0% | +47.6% | -2.3% | |
| – | +49.9% | +1.8% | +16.7% | -1.9% | +6.6% | +27.5% | |
| – | +20.1% | +37.0% | +56.3% | -2.3% | -10.1% | -14.9% | |
| – | +8.6% | +4.0% | +96.4% | – | – | – | |
| – | – | +183.5% | +0.0% | +0.0% | +7.0% | +316.4% | |
| – | – | +69.8% | +0.2% | -5.9% | +6.7% | +620.6% | |
| – | +35.8% | +37.4% | -20.3% | +51.4% | -28.9% | +28.2% | |
| – | +60.7% | +17.1% | +11.4% | +22.2% | +16.4% | +25.1% | |
| – | – | – | – | -0.6% | -17.0% | -3.1% | |
| – | -11.8% | +101.9% | -51.7% | +79.6% | +33.7% | +52.0% | |
| – | +8.5% | -215.0% | – | -53.7% | +882.2% | +44.1% | |
| – | -13.0% | +176.8% | +154.0% | -40.7% | -239.5% | – | |
| – | +0.0% | -13.7% | +21.0% | -2.7% | +10.2% | +19.3% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.